ENXTAM:AGN
ENXTAM:AGNInsurance

Does Aegon (ENXTAM:AGN)’s Buyback and US Rebrand Mark a Turning Point in Its Capital Priorities?

Aegon Ltd. has announced a €400 million share repurchase program for 2026, split evenly between the first and second half of the year, alongside Board approval of a new buyback plan and an ongoing review of non-US units that could include Aegon UK and its majority stake in a Santander insurance joint venture. These moves come as Aegon works to shift its headquarters and legal seat to the US and rebrand as Transamerica Inc., underlining a clear push to concentrate governance, capital, and...
ENXTAM:ASML
ENXTAM:ASMLSemiconductor

Nieuwsuus China Export Report Could Be A Game Changer For ASML Holding (ENXTAM:ASML)

Recently, Dutch program Nieuwsuur reported that ASML had supplied parts to a Chinese firm allegedly linked to the country’s military, prompting the company to reiterate that all exports either fall outside licensing rules or have been cleared by the Dutch government. This raises fresh questions for investors about ASML’s exposure to geopolitics and export controls at a time when its technology is central to advanced chip manufacturing. Next, we’ll examine how heightened scrutiny of ASML’s...
ENXTAM:WKL
ENXTAM:WKLProfessional Services

How Wolters Kluwer’s AI Tax And Clinical Tools Push (ENXTAM:WKL) Has Changed Its Investment Story

Earlier this week, Wolters Kluwer Tax & Accounting Germany launched SteuerSparErklärung Online, a browser-based tax filing platform that uses the AI assistant “Alma” to answer natural-language tax questions, while Wolters Kluwer Health’s Ovid Synthesis was adopted by the American Board of Medical Specialties Portfolio Program as an official quality improvement workflow tool. Together, these moves highlight Wolters Kluwer’s push to embed AI and cloud delivery into everyday professional...
ENXTAM:INGA
ENXTAM:INGABanks

How Investors May Respond To ING Groep (ENXTAM:INGA) Buyback And Transparency Push

Earlier in December 2025, ING Groep reported that it had repurchased 1,710,214 shares under its ongoing €1.10 billion buyback, bringing total repurchases to 11,382,155 shares, while its American depositary receipts traded modestly higher alongside other European names in US markets. At the same time, ING’s confirmation of participation in the European Banking Authority’s 2025 Transparency Exercise underlines its focus on regulatory disclosure as it returns capital through a sizeable buyback...
ENXTAM:ASM
ENXTAM:ASMSemiconductor

ASM International (ENXTAM:ASM) Valuation After Morgan Stanley Top Pick Call and CEO Reappointment

Morgan Stanley putting ASM International (ENXTAM:ASM) at the top of its European chips list, together with a planned second term for CEO Hichem M Saad, has sharpened investor focus on the stock. See our latest analysis for ASM International. The bullish call from Morgan Stanley, combined with CEO continuity, comes as ASM International’s share price has surged, including a 6.92% 1 day share price return and 30.98% 90 day share price return. Its 5 year total shareholder return of 245.10%...
ENXTAM:THEON
ENXTAM:THEONAerospace & Defense

Assessing Theon International (ENXTAM:THEON) Valuation After a Year of Powerful Share Price Gains

Theon International (ENXTAM:THEON) has quietly delivered a strong run this year, with the stock nearly doubling over the past 12 months, prompting investors to ask whether the current valuation still looks reasonable. See our latest analysis for Theon International. With the latest share price sitting at $32.0 and a powerful year to date share price return of 142.42 percent plus a one year total shareholder return of 197.36 percent, momentum clearly looks to be building as investors reassess...
ENXTAM:PHIA
ENXTAM:PHIAMedical Equipment

The Bull Case For Philips (ENXTAM:PHIA) Could Change Following AI-Driven, Radiation-Free Imaging Launches

In recent weeks, Royal Philips reiterated its 2026 earnings guidance and unveiled two major RSNA 2025 innovations: LumiGuide, an AI-enabled, radiation-free 3D navigation solution now commercially available across Europe and the US, and BlueSeal Horizon, a helium-free 3.0T MRI platform aimed at simplifying installation and reducing lifecycle risk. Together, these advances highlight Philips’ push to pair intelligent imaging with sustainability, potentially reshaping how hospitals approach...
ENXTAM:PRX
ENXTAM:PRXMultiline Retail

Prosus (ENXTAM:PRX): Reassessing Valuation After Strong Half-Year Earnings Jump in Sales and Net Income

Prosus (ENXTAM:PRX) just paired a strong earnings beat with a big capital return story, as half year sales and net income jumped sharply, which puts the recent share price pullback into a different light. See our latest analysis for Prosus. Even after a 13.05% 1 month share price pullback and a softer 7 day move, Prosus still boasts a hefty 34.55% year to date share price return and a 77.31% three year total shareholder return, suggesting longer term momentum remains firmly intact. If Prosus...
ENXTAM:PHIA
ENXTAM:PHIAMedical Equipment

Does Philips Share Price Reflect Its Recovery After Product Safety Settlements?

If you are wondering whether Koninklijke Philips is a bargain or a value trap at around €22.72, this article will walk you through what the numbers actually say, without the noise. The stock has pulled back recently, down 6.2% over the last week, 7.4% over the past month, and 7.2% year to date, but it is still up 92.9% over three years despite being 37.7% lower than five years ago. These moves follow a series of developments around product safety settlements and ongoing restructuring, which...
ENXTAM:ADYEN
ENXTAM:ADYENDiversified Financial

Adyen (ENXTAM:ADYEN) Valuation Check as Shares Drift Lower Despite Ongoing Double-Digit Growth

Adyen (ENXTAM:ADYEN) has quietly drifted lower this year, and that slide is turning heads. With the stock down about 7% year to date, investors are rechecking what they are actually paying for. See our latest analysis for Adyen. The recent slide adds to what has been a choppy stretch, with a 30 day share price return of minus 5.7% and a 1 year total shareholder return near minus 10%, suggesting momentum is still fading despite solid underlying growth. If Adyen’s pullback has you reassessing...
ENXTAM:HEIA
ENXTAM:HEIABeverage

Heineken (ENXTAM:HEIA): Assessing Valuation After a Steady 4% Share Price Climb

Heineken (ENXTAM:HEIA) has quietly climbed about 4% over the past month and past 3 months, a steady move that has investors asking whether this slow re-rating has more room to run. See our latest analysis for Heineken. That recent 1 month share price return of around 4% comes after a muted year to date move, while the 1 year total shareholder return is still only in the low single digits. This suggests sentiment is stabilising rather than surging. If Heineken’s slow grind higher has you...
ENXTAM:ABN
ENXTAM:ABNBanks

European Dividend Stocks To Consider Now

As European markets experience a positive uptick, with the pan-European STOXX Europe 600 Index rising by 2.35% and major single-country indexes also posting gains, investors are keenly observing how subdued inflation rates could influence future economic stability in the region. In this context, dividend stocks emerge as an attractive option for those looking to balance potential growth with steady income, offering a buffer against market volatility while capitalizing on Europe's current...
ENXTAM:MT
ENXTAM:MTMetals and Mining

ArcelorMittal (ENXTAM:MT): Assessing Valuation as France Pushes for Nationalization to Halt Job Cuts

France's lower house recently voted to nationalize ArcelorMittal (ENXTAM:MT) in an effort to block planned job cuts. This move puts increased political and operational uncertainty front and center for investors tracking the stock. See our latest analysis for ArcelorMittal. While France’s push to nationalize ArcelorMittal has added fresh uncertainty, the market seems to be running with it. A 1-day share price return of 1.45% capped a 65% climb so far this year, and the stock’s 1-year total...
ENXTAM:AGN
ENXTAM:AGNInsurance

Does Aegon’s 19.7% Rally Reveal More Value After Streamlining Its Business in 2025?

If you have ever wondered whether Aegon stock is trading below its true worth, you are not alone. Let's dig into where the value could really be hiding. Aegon's share price has impressed lately, climbing 6.7% over the last month and amassing a strong 19.7% gain year-to-date, topping that off with an impressive 21.2% return over the past year. Investors’ optimism seems to have been boosted by recent reports of Aegon successfully streamlining its business by focusing more on strategic core...
ENXTAM:CRBN
ENXTAM:CRBNChemicals

Corbion (ENXTAM:CRBN): Is the Recent Share Price Upswing Justified by Its Valuation?

Corbion (ENXTAM:CRBN) stock moved higher today, catching the attention of market watchers. Investors appear to be weighing recent performance trends and updates across its food ingredients and bioplastics segments. See our latest analysis for Corbion. Corbion’s 2.6% share price gain today builds on an impressive 15.96% jump over the past month, signaling renewed confidence among investors. Still, the one-year total shareholder return remains negative at -6.8%, reflecting a challenging...